Alberta Investment Management Corp Acquires New Holdings in agilon health, inc. (NYSE:AGL)

Alberta Investment Management Corp bought a new stake in shares of agilon health, inc. (NYSE:AGL) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 823,120 shares of the company’s stock, valued at approximately $1,564,000. Alberta Investment Management Corp owned 0.20% of agilon health as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of AGL. Rhumbline Advisers grew its holdings in agilon health by 6.2% in the 4th quarter. Rhumbline Advisers now owns 419,587 shares of the company’s stock worth $797,000 after buying an additional 24,420 shares in the last quarter. Empowered Funds LLC acquired a new position in shares of agilon health during the fourth quarter valued at $97,000. First Citizens Bank & Trust Co. bought a new stake in shares of agilon health during the fourth quarter valued at about $46,000. Inspire Investing LLC lifted its holdings in agilon health by 106.6% in the fourth quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock worth $413,000 after purchasing an additional 112,241 shares during the period. Finally, Oak Thistle LLC bought a new position in agilon health in the 4th quarter valued at about $25,000.

Insider Transactions at agilon health

In other agilon health news, Director Diana Mckenzie acquired 12,500 shares of agilon health stock in a transaction that occurred on Monday, November 25th. The stock was purchased at an average cost of $2.28 per share, with a total value of $28,500.00. Following the purchase, the director now owns 51,319 shares in the company, valued at approximately $117,007.32. The trade was a 32.20 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director John William Wulf bought 45,000 shares of the stock in a transaction on Thursday, December 5th. The shares were acquired at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the purchase, the director now owns 206,133 shares in the company, valued at approximately $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired a total of 90,000 shares of company stock valued at $198,100 over the last quarter. Company insiders own 3.20% of the company’s stock.

agilon health Trading Down 2.6 %

agilon health stock opened at $3.53 on Friday. The company has a 50 day moving average price of $2.82 and a 200 day moving average price of $3.11. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. agilon health, inc. has a 52 week low of $1.50 and a 52 week high of $7.73. The firm has a market capitalization of $1.45 billion, a price-to-earnings ratio of -3.75 and a beta of 0.67.

Analyst Upgrades and Downgrades

A number of research firms recently commented on AGL. Macquarie started coverage on shares of agilon health in a research note on Monday, December 16th. They set a “neutral” rating and a $3.00 price objective on the stock. JMP Securities cut agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Barclays cut their price objective on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a report on Monday, November 11th. Sanford C. Bernstein raised their target price on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research note on Wednesday, January 15th. Finally, TD Cowen cut their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a report on Monday, November 11th. Two investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $4.03.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.